News & Events

New Things

News & Events

New Things

Press Releases

January 9th, 2026
The Value of Biomarkers in Selecting the “Right Target” and the “Right Patient”
January 6th, 2026
TrilliumBiO at RESI JPM: Advancing Biomarker Discovery into Patient-Ready Diagnostics
December 9th, 2025
TrilliumBiO and Oncobit Partner to Bring Novel Uveal Melanoma Monitoring Solution to the U.S.
November 21st, 2025
The Power of Early Alzheimer’s Diagnosis
November 3rd, 2025
TrilliumBiO Partners With BioHub Maryland, Powered by Maryland Tech Council, as Elite Partner
October 22nd, 2025
TrilliumBiO Presented Data on GM-CSF Autoantibody Testing Using Dried Blood Spot Collection at CHEST 2025 in Chicago, Illinois
September 29th, 2025
TrilliumBiO Presented Data on GM-CSF Autoantibody Testing Using Dried Blood Spot Collection at the European Respiratory Society (ERS) Congress in Amsterdam, Netherlands
September 2nd, 2025
TrilliumBiO: Advancing Diagnostics and Innovation in Montgomery County, MD
July 29th, 2025
TrilliumBiO and T-NeuroDx Announce Strategic Collaboration to Commercialize Blood-Based Biomarkers for Alzheimer’s Disease
July 7th, 2025
Maryland Tech Council Welcomes Twelve Industry Leaders to its Board of Directors

12 Next

Recent presentations

Upcoming Events

February 3, 2026

MTC Annapolis Day 2026: Advocacy Summit & Leadership Reception

February 19-20, 2026

Frontiers 2026: Phase Capital’s Third Annual Summit

February 23, 2026

FDA Rare Disease Day

February 27, 2026

Rare Disease Day at NIH

March 17-19, 2026

The Rare Disease Summit by Informa

May 17-19, 2026

ATS International Conference 2026

We collaborate with world-class industry leaders to deliver innovative diagnostic solutions to underserved communities, improving health and well-being worldwide.

PARTNER WITH US TO TRANSFORM HEALTH

New Things

New Things

Press Releases

The Value of Biomarkers in Selecting the “Right Target” and the “Right Patient”

TrilliumBiO at RESI JPM: Advancing Biomarker Discovery into Patient-Ready Diagnostics

TrilliumBiO and Oncobit Partner to Bring Novel Uveal Melanoma Monitoring Solution to the U.S.

The Power of Early Alzheimer’s Diagnosis

TrilliumBiO Partners With BioHub Maryland, Powered by Maryland Tech Council, as Elite Partner

TrilliumBiO Presented Data on GM-CSF Autoantibody Testing Using Dried Blood Spot Collection at CHEST 2025 in Chicago, Illinois

TrilliumBiO Presented Data on GM-CSF Autoantibody Testing Using Dried Blood Spot Collection at the European Respiratory Society (ERS) Congress in Amsterdam, Netherlands

TrilliumBiO: Advancing Diagnostics and Innovation in Montgomery County, MD

TrilliumBiO and T-NeuroDx Announce Strategic Collaboration to Commercialize Blood-Based Biomarkers for Alzheimer’s Disease

Maryland Tech Council Welcomes Twelve Industry Leaders to its Board of Directors

Recent presentations

Retrospective Analysis of Alpha-1 Antitrypsin Serum Levels and Genotype Correlation from the AlphaID™ Confirm Testing Program

Development of a Dried Blood Spot Assay for The Detection of GM-CSF Autoantibodies to Aid in The Diagnosis of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Expanding the Diagnostic Screening of Alpha-1 Antitrypsin Deficiency: Evaluation of the AlphaID™ Test in Detecting Rare SERPINA1 Variants

Development of a Novel Laboratory Test for the Detection of GM-CSF Autoantibodies to Aid in the Diagnosis of Individuals At-risk for Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Upcoming Events